FDA files Class II recall of Victory Medical Center Pharmacy B complex
A 30ml B complex product from the pharmacy is subject to an open recall in Colorado, Florida and Texas, though the size of the commercial exposure is not disclosed.
11 Nov 2026 · FDA enforcement report · Regulator
The commercial weight of a new US drug recall depends on volume, lots and the length of the supply chain affected. For the Victory Medical Center Pharmacy action, the public record gives none of that, so any financial or supply impact cannot be sized.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on CompePharma and VigiEye
- One subscription for both sites, cancel any time
or
Official record: FDA enforcement report ↗
Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.
More Manufacturing & supplyAll →
Manufacturing & supply
Health Canada lists Class II recall of Stryker's Blueprint shoulder-planning software over two bugs
18 Nov 2026 · Health Canada · Regulator
Manufacturing & supply
Teleflex recalls PICC kits and spring-wire guides over coating detachment risk, Health Canada reports
18 Nov 2026 · Health Canada · Regulator
Manufacturing & supply
Health Canada: Raz Design recalls shower commode chairs over seats that can break
18 Nov 2026 · Health Canada · Regulator
Manufacturing & supply
Lantern Pharma opens first TNBC trial site, starts HARMONIC Part 2 in Taiwan; CEO resigns
18 Nov 2026 · Lantern Pharma Inc. LTRN · Company news
Manufacturing & supply
OXB confirms manufacturing deal with Aura Biosciences for bel-sar Phase 3 and commercial supply
17 Nov 2026 · OXB · Company news
Manufacturing & supply
Diagnostica Stago recalls lot of STHEMO DDi M, Dutch inspectorate notice shows
17 Nov 2026 · IGJ · Regulator